Research Areas
► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)
► Food and Drug Administration (FDA)
► technologies (e.g., drugs, devices, AI, cybersecurity)
Metholodogical Approach
► guided by economic and sociological theory
► quantitative (statistical / econometric) methods
► large administrative, survey, and other datasets
Recent Activity
>> European Medicines Agency Jordi Llinares Lecture <<
April 2026
>> New Working Paper<<
April 2026
Profit regulation and strategic transfer pricing by vertically integrated firms: Evidence from health care. NBER Working Paper 35043.
>> New Publication<<
March 2026
Conflicts of interest in advisory committees — facts, fallacies, and the limits of reform. [PDF] [original ms] N Engl J Med 2026; 394:1150-1152.
GBH Public Radio
Curiosity Desk
May 5, 2026
FDA review of psychedelic drugs [audio] [video]
Interview with Edgar B Herwick III
Medscape
April 29, 2026
The unprecedented rise of scientists fact-checking the Feds [PDF]
by Lisa Marshall
STAT News
April 1, 2026
Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest [PDF]
by Ed Silverman